Michael H. Ieong, MD
Assistant Professor
Boston University School of Medicine
Dept of Medicine
Pulmonary, Allergy, Sleep & Critical Care Medicine

MD, University of Illinois




Dr. Ieong is an Assistant Professor in the Department of Medicine. He attends in the Medical Intensive Care Unit and on the Pulmonary Consult service of Boston Medical Center. He sees patients in the Pulmonary and Allergy outpatient clinic and oversees the cardiopulmonary exercise testing program.

Dr. Ieong's focus is on translational medicine. His research focuses on the innate immunity of the lung in response to infection, particularly in the context of immune compromise such as HIV-infection. His clinical expertise is in critical care medicine and the administration of intensive care units.

Dr. Ieong is a NIH-funded Principal Investigator with research focused on the role of the alveolar macrophage and monocyte in host immunity and HIV-related lung pathogenesis. Projects in the lab study the redox regulation of HIV expression in alveolar macrophages; the role of IL-16 in HIV-infection of alveolar macrophages; and, HIV-induced impairment of alveolar macrophage handling of C. neoformans. He is an experienced research bronchoscopist and collaborates with a number of investigators to provide primary lung cells and lavage for study. He is a member of the Pulmonary Immunology Group and the Center for HIV/AIDS Care and Research.

Research special interests include:
-HIV pathogenesis in the lung
-Redox cell signaling pathways
-Alveolar macrophage biology
-Innate immunity of the lung

Clinical special interests include:
-HIV-related lung disease
-General pulmonary medicine
-Exercise physiology

Member
Boston University
Pulmonary Center




Redox Regulated HIV Expression in Alveolar Macrophages
08/15/2003 - 11/30/2008 (PI)
NIH/National Heart, Lung, and Blood Institute
5 K08 HL73671 05


COVID-PACT A Multicenter, Randomized-Controlled Trial to Evaluate the Efficacy and Safety of Antithrombotic Therapy for Prevention of Arterial and Venous Thrombotic Complications in Critically-Ill COVID-19 Patients
09/14/2020 - 09/13/2023 (PI)
Brigham and Womens Hospital

ECU-COV-401: SOLIRIS® (eculizumab) for the Treatment of Participants with Coronavirus Disease…
06/16/2020 - 06/15/2023 (PI)
Alexion Pharmaceuticals

ALXN1210-COV-305: A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the…
06/08/2020 - 06/07/2023 (PI)
Alexion Pharmaceuticals


Title

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Nadjarian A, LeClair J, Mahoney TF, Awtry EH, Bhatia JS, Caruso LB, Clay A, Greer D, Hingorani KS, Horta LFB, Ibrahim M, Ieong MH, James T, Kulke MH, Lim R, Lowe RC, Moses JM, Murphy J, Nozari A, Patel AD, Silver B, Theodore AC, Wang RS, Weinstein E, Wilson SA, Cervantes-Arslanian AM. Validation of a Crisis Standards of Care Model for Prioritization of Limited Resources During the Coronavirus Disease 2019 Crisis in an Urban, Safety-Net, Academic Medical Center. Crit Care Med. 2021 Jun 09.View Related Profiles. PMID: 34115635
     
  2. Bosch NA, Crable EL, Ackerbauer KA, Clark K, Drainoni ML, Grim V, Ieong MH, Walkey AJ, Murphy J. Implementation of a Phenobarbital-based Pathway for Severe Alcohol Withdrawal: A Mixed-Methods Study. Ann Am Thorac Soc. 2021 May 04.View Related Profiles. PMID: 33945771
     
  3. Garcia MA, Rampon GL, Doros G, Jia S, Jagan N, Gillmeyer K, Berical A, Hudspeth J, Ieong M, Modzelewski KL, Schechter-Perkins EM, Ross CS, Rucci JM, Simpson S, Walkey AJ, Bosch NA. Rationale and Design of the Awake Prone Position for Early Hypoxemia in COVID-19 (APPEX-19) Study Protocol. Ann Am Thorac Soc. 2021 Mar 01.View Related Profiles. PMID: 33647225
     
  4. Sinha P, Mostaghim A, Bielick CG, McLaughlin A, Hamer DH, Wetzler LM, Bhadelia N, Fagan MA, Linas BP, Assoumou SA, Ieong MH, Lin NH, Cooper ER, Brade KD, White LF, Barlam TF, Sagar M. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int J Infect Dis. 2020 Oct; 99:28-33.View Related Profiles. PMID: 32721528; PMCID: PMC7591937; DOI: 10.1016/j.ijid.2020.07.023;
     
  5. Stephens AR, Wiener RS, Ieong MH. Comparison of Methods To Identify Advance Care Planning in Patients with Severe Chronic Obstructive Pulmonary Disease Exacerbation. J Palliat Med. 2018 03; 21(3):284-289.View Related Profiles. PMID: 28850288; PMCID: PMC5863063; DOI: 10.1089/jpm.2017.0251;
     
  6. Kozlowski E, Wasserman GA, Morgan M, O'Carroll D, Ramirez NP, Gummuluru S, Rah JY, Gower AC, Ieong M, Quinton LJ, Mizgerd JP, Jones MR. The RNA uridyltransferase Zcchc6 is expressed in macrophages and impacts innate immune responses. PLoS One. 2017; 12(6):e0179797.View Related Profiles. PMID: 28665939; PMCID: PMC5493306; DOI: 10.1371/journal.pone.0179797;
     
  7. Ozsancak Ugurlu A, Sidhom SS, Khodabandeh A, Ieong M, Mohr C, Lin DY, Buchwald I, Bahhady I, Wengryn J, Maheshwari V, Hill NS. Use and Outcomes of Noninvasive Ventilation for Acute Respiratory Failure in Different Age Groups. Respir Care. 2016 Jan; 61(1):36-43. PMID: 26374908
     
  8. Ozsancak Ugurlu A, Sidhom SS, Khodabandeh A, Ieong M, Mohr C, Lin DY, Buchwald I, Bahhady I, Wengryn J, Maheshwari V, Hill NS. Where is Noninvasive Ventilation Actually Delivered for Acute Respiratory Failure? Lung. 2015 Oct; 193(5):779-88. PMID: 26210474
     
  9. Man A, Davidyock T, Ferguson LT, Ieong M, Zhang Y, Simms RW. Changes in forced vital capacity over time in systemic sclerosis: application of group-based trajectory modelling. Rheumatology (Oxford). 2015 Aug; 54(8):1464-71.View Related Profiles. PMID: 25784774; DOI: 10.1093/rheumatology/kev016;
     
  10. Hyatt LD, Wasserman GA, Rah YJ, Matsuura KY, Coleman FT, Hilliard KL, Pepper-Cunningham ZA, Ieong M, Stumpo DJ, Blackshear PJ, Quinton LJ, Mizgerd JP, Jones MR. Myeloid ZFP36L1 does not regulate inflammation or host defense in mouse models of acute bacterial infection. PLoS One. 2014; 9(10):e109072.View Related Profiles. PMID: 25299049; PMCID: PMC4192124; DOI: 10.1371/journal.pone.0109072;
     
Showing 10 of 19 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 19 publications over 11 distinct years, with a maximum of 3 publications in 2015 and 2021

YearPublications
19991
20001
20021
20062
20082
20101
20142
20153
20172
20201
20213
Contact for Mentoring:

72 E. Concord St Housman (R)
Boston MA 02118
Google Map


Ieong's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department